Soy isoflavones

Soy isoflavones are a group of plant-derived polyphenolic compounds, primarily comprising genistein, daidzein, and glycitein, which are found in high concentrations in soybeans and soy-based products. They are classified as phytoestrogens due to their structural similarity to 17β-estradiol, allowing them to bind to human estrogen receptors and exert both weak estrogenic and anti-estrogenic effects depending on the tissue type. Beyond their hormonal activity, soy isoflavones are recognized for their antioxidant properties and their ability to inhibit protein tyrosine kinases, which are critical in regulating cell growth and survival. These compounds are extensively researched for their potential clinical benefits in alleviating menopausal symptoms, maintaining bone mineral density to prevent osteoporosis, and reducing the risk of cardiovascular disease and certain cancers, such as breast and prostate cancer. However, the efficacy and safety of soy isoflavones are influenced by individual metabolic differences, notably the ability of gut microbiota to convert daidzein into the more biologically active metabolite, S-equol.

Other names

PhytoestrogensSoy phytoestrogensGenisteinDaidzeinGlycitein

Soy isoflavones function primarily as Selective Estrogen Receptor Modulators (SERMs), binding to Estrogen Receptor alpha (ERα) and Estrogen Receptor beta (ERβ), with a significantly higher affinity for ERβ (PMID: 9336040). They also act as inhibitors of protein tyrosine kinases, particularly genistein, which interferes with signal transduction pathways involved in cell proliferation (PMID: 3290234). Additionally, they demonstrate antioxidant properties by scavenging reactive oxygen species and can inhibit DNA topoisomerase II (PMID: 10329042).